ResearcherUniversity Hospital ZurichActive in the last 2 years
José Oberholzer
Matched on ORCID iD 0000-0002-1069-2501; OpenAlex author ID A5044801580. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 27
2026: 4 papers
Papers 4
- Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis. Co-author DOI 10.1093/jnci/djag235↗
- Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Co-author DOI 10.1245/s10434-026-19841-5↗
- ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-anal… Co-author DOI 10.1245/s10434-026-19926-1↗
- Targeting IL-12 for pancreatic cancer immunotherapy: advances in delivery strategies and clinical translation. Last author DOI 10.3389/fimmu.2026.1755796↗
Closest collaborators
The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ning Pu · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Dilmurodjon Eshmuminov · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Víctor López‐López · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Michael C. Frey · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- So Heun Lee · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Ralph Fritsch · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Changhoon Yoo · 3 shared papers, 2026 · strength 0.69
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Paper Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-pac… DOI 10.1093/jnci/djag235↗
- Bradley Norman Reames · 2 shared papers, 2026 · strength 0.50
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Haleh Amirian · 2 shared papers, 2026 · strength 0.50
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Chunmeng Zhang · 2 shared papers, 2026 · strength 0.50
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Jashodeep Datta · 2 shared papers, 2026 · strength 0.50
- Paper Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic R… DOI 10.1245/s10434-026-19841-5↗
- Paper ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic C… DOI 10.1245/s10434-026-19926-1↗
- Jessica N. Schlatter · 1 shared paper, 2026 · strength 0.33
- Syed A. Ahmad · 1 shared paper, 2026 · strength 0.19
- Giuseppe Malleo · 1 shared paper, 2026 · strength 0.19
- Gregory C. Wilson · 1 shared paper, 2026 · strength 0.19
- Ryan K. Schmocker · 1 shared paper, 2026 · strength 0.19
- Jin Peng He · 1 shared paper, 2026 · strength 0.19
- Russell F. Palm · 1 shared paper, 2026 · strength 0.19
- Liang Liu · 1 shared paper, 2026 · strength 0.19
- Patricia Sánchez‐Velázquez · 1 shared paper, 2026 · strength 0.19
- Benedetto Ielpo · 1 shared paper, 2026 · strength 0.19
- Elena B. Rangelova · 1 shared paper, 2026 · strength 0.19
- Gabriella Lionetto · 1 shared paper, 2026 · strength 0.19
- Sarah E. Hoffe · 1 shared paper, 2026 · strength 0.19
- Timothy Michael Pawlik · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.